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SUMMARY 
Most in vivo gene therapies will require cell-specific targeting.  Although vector targeting 
through ligand attachment has met with success in generating gene delivery particles that are 
capable of specific cellular interactions, little attention has been given to the possible effects of 
such ligands on subsequent intracellular processing.  In this study, we examine the impact of 
targeting two distinct endocytic routes—the caveolar and clathrin pathways—on 
polyethylenimine-mediated gene delivery in HeLa cells.  Targeting complexes to the caveolar 
pathway with folic acid and the clathrin pathway with transferrin yields enhanced gene delivery 
relative to unmodified polyethylenimine.  Colocalization studies with caveolin-1 and clathrin 
heavy chain indicate that the ligands successfully deliver their cargo to the intended pathways.  
However, inhibition of only the caveolar pathway—whether through the use of small molecule 
drugs or RNA interference—reduces gene delivery efficiency, suggesting that successful 
polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells.  
Transfections in the presence of chloroquine and pH tracking studies suggest that a contributing 
factor to the success of the caveolar pathway is avoidance of lysosomes.  Collectively, these data 
demonstrate that uptake mechanism and subsequent endocytic processing are important design 
parameters for gene delivery materials.   
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INTRODUCTION 
 
The most effective gene delivery strategy for a given application is often dictated by particular 
disease characteristics.  For systemic diseases like hemophilia, treating any of a number of 
tissues or cell types may be adequate provided that sufficient levels of the transgene product are 
expressed and have access to the circulatory system.1  However, for localized disorders like 
cancer or cystic fibrosis, it is often beneficial and sometimes critical to target gene delivery 
vectors to specific diseased cell types.2,3  It has been reported that the “receptors” for 
polycationic gene delivery vectors are clusters of negatively charged proteoglycans on the cell 
surface.  Unfortunately, these “receptors” do not afford cell specificity. 4  To direct gene delivery 
vehicles to particular cells, peptides, proteins or small molecule ligands may be attached to the 
surface of polyplexes.5-8  Ideally, the ligand chosen would target a receptor found on only one 
particular type of diseased cell, thereby ensuring that healthy cells are unaffected.  While such 
targeting methods have met with success in generating particles that are capable of specific 
cellular interactions, little attention has been given to the possible effects on the intracellular 
trafficking of targeted gene delivery complexes. 
 
Transferrin and folic acid are commonly used ligands for drug and gene targeting due to the 
overexpression of their respective receptors on many cancer cells.9-11  Notably, these ligands 
utilize different uptake mechanisms which ultimately result in distinct intracellular processing.  
Transferrin is internalized by clathrin-coated pits and follows the traditional endolysosomal 
pathway.12  More specifically, upon ligand binding, clathrin is recruited to receptor sites, forming 
a cage-like structure that stabilizes the vesicle as it buds from the membrane.  As the endocytic 
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vesicle moves through the cell, proton pumps anchored within its membrane gradually acidify 
the vesicle contents from approximately pH 7.2 to pH 6.  At this pH, the vesicle is termed an 
early endosome.  Through continued acidification, the early endosome eventually reaches pH 5 
at which point it is considered a late endosome.  Finally, when the endosome has fully matured, 
it fuses with lysosomes and reaches a pH as low as 4.5 where degradative enzymes are activated.   
 
Folic acid, in contrast, is internalized by caveolae—flask-like invaginations on the cell surface 
that bud from membrane microdomains rich in cholesterol and the protein caveolin.13  Upon 
receptor/ligand binding, the cell membrane pinches off to form a vesicle that is directed towards 
caveosomes.  Endocytosis through caveolae and the fate of caveosomes are less well understood 
than its clathrin-mediated counterpart.  There is speculation that caveosomes may fuse with early 
endosomes through the action of the GTPase Rab5 or proceed through the cell by an independent 
path.14  Unlike the clathrin pathway, however, caveosomes avoid trafficking to lysosomes.  In the 
case of the cholera toxin binding subunit (CTxB), one of the better studied ligands utilizing 
caveolar uptake, the ligand is believed to be transported to the Golgi complex via early 
endosomes.15,16  Simian virus 40 (SV40), which also utilizes caveolar uptake, is thought to avoid 
the harsh pH and enzymatic environment of the endosomal-lysosomal pathway and remain 
entirely in pH-neutral caveosomes at it travels through the cell.17,18 
 
Polyethylenimine (PEI) is an efficient off-the-shelf gene delivery material.  It is believed that the 
relatively high gene delivery efficiency of PEI is attributable to its ability to act as a proton 
sponge.19  According to the proton sponge hypothesis, these polyplexes are sequestered in 
endocytic vesicles that are acidified by V-type ATPases within the endosomal membrane.  PEI, 
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with its abundance of primary, secondary and tertiary amines, is thought to effectively buffer the 
vesicle lumen.  As increasing numbers of protons and counter ions are pumped in to acidify the 
buffered compartment, water is osmotically driven into the lumen.  The excess water is believed 
to cause swelling and eventual lysis of the endosome, releasing polyplexes into the cytosol.  This 
proposed mechanism for the endosomal escape of proton sponge-containing polyplexes has been 
met with both corroborating and conflicting data.20-23  Recently, we demonstrated that acetylation 
of PEI resulting in decreased buffering capacity—as well as weaker interactions with nucleic 
acids—significantly improved gene delivery efficiency, suggesting that the proton-sponge effect 
may not be a complete representation of the intracellular processing of such polyplexes.24,25  The 
study presented here examines the importance of the caveolar uptake pathway that potentially 
avoids vesicle acidification and thus precludes the proton sponge effect, compared to the 
clathrin-mediated uptake pathway that is inherently tied with endosome acidification, on PEI-
mediated transfection of HeLa cells. 
 
RESULTS 
 
Generation of folate-targeted PEI 
NHS-folate was conjugated to 25-kDa branched polyethylenimine at 1.1, 3.2 and 7.2 folate 
molecules per PEI (PEI-Fol).  When subsequently used to transfect the HeLa cervical cancer cell 
line, known to overexpress folate receptors, PEI-Fol with 1.1 folate moieties per polymer chain 
[PEI-Fol(1.1)] yielded gene expression levels roughly five-fold greater than unmodified PEI, 
albeit only at the sub-optimal polymer:DNA weight ratio of 0.5:1 (p < 0.1, Figure 1a).  This is 
likely due to non-specific electrostatic interactions between the negatively charged cell 
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membrane and positively charged polyplexes at higher weight ratios.  For subsequent 
experiments, transfections were performed with complexes formed at the polymer:DNA weight 
ratio of 0.5:1 using PEI-Fol(1.1).  The uptake of targeted and non-targeted polyplexes was 
similar at times up to one hour post-transfection.  Corresponding with the increased transfection 
efficiency, PEI-Fol(1.1)/DNA polyplexes showed a 1.5-fold increase in uptake in HeLa cells 
relative to unmodified PEI polyplexes at two and four hours post-transfection. (p < 0.05, Figure 
1b).  The delayed uptake of PEI-Fol(1.1)/DNA complexes is likely due to the slow kinetics of 
caveolae-mediated uptake.9, 26, 27.  To verify that folate-targeted complexes entered cells through 
folate receptors, a competitive inhibition assay was performed.  Addition of 100 to 300 μM free 
folic acid to the transfection medium reduced PEI-Fol(1.1)/DNA-mediated luciferase expression 
by roughly four-fold relative to folate-free conditions (p < 0.05, Figure 1c).  Free folic acid also 
reduced the uptake of PEI-Fol(1.1)/DNA by 25% relative to uptake in the absence of folic acid 
(p < 0.05, Figure 1d).  Combined, the data indicate that at least a portion of the folate-targeted 
complexes entered cells via the folate receptor. 
 
Generation of transferrin-targeted PEI 
HeLa cells were transfected with transferrin-targeted PEI complexes formed at a total 
polymer:DNA weight ratio of 0.5:1, based on the results described above, to limit non-specific 
electrostatic interactions with cell membrane components.  Following the procedure of Kircheis 
et al., the complexes were formed with varying ratios of unmodified PEI to transferrin-targeted 
PEI.8  Polyplexes composed of between 10% and 50% PEI-Tf yielded gene expression levels 
between two- and eight-fold higher than unmodified PEI (p < 0.05, Figure 2a).  Polyplexes 
composed of 25% PEI-Tf and 75% unmodified PEI [PEI-Tf(25%)] were used for subsequent 
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experiments.  Corresponding with the increased transfection efficiency, uptake of PEI-
Tf(25%)/DNA increased two-fold relative to unmodified PEI at one (p < 0.1), two and four (p < 
0.05) hours post-transfection (Figure 2b).  The more rapid uptake of transferrin-targeted 
complexes relative to untargeted complexes—observable even after 30 minutes—is likely 
attributable to the faster kinetics of clathrin-mediated uptake.27-29  To verify the targeting of 
transferrin receptors by PEI-Tf(25%), transfection experiments were performed in the presence 
of free transferrin.  The presence of 0.5 μM transferrin in the transfection medium reduced the 
PEI-Tf(25%)/DNA-mediated luciferase expression by approximately 60% relative to transferrin-
free conditions, but the difference was not statistically significant (p < 0.15, Figure 2c).  Further 
inhibition was possible at higher concentrations of free transferrin, but the specificity of the 
inhibition decreased—the electrostatic interactions between negatively charged transferrin and 
the cationic PEI substantially reduced the gene delivery efficiency of targeted as well as 
untargeted complexes (data not shown).  The presence of 0.5 μM transferrin also reduced the 
uptake of PEI-Tf(25%)/DNA by 30% relative to transferrin-free conditions, but again the 
difference was not statistically significant (p < 0.15, Figure 2d). 
 
Investigation of complex colocalization with caveolin-1 and clathrin heavy chain 
As mentioned previously, folic acid is endocytosed via a caveolar pathway while transferrin 
enters cells in a clathrin-mediated fashion.  To verify that folate- and transferrin-targeted PEI 
complexes indeed enter HeLa cells through their intended pathways, confocal microscopy was 
performed to investigate the colocalization between fluorescently-labeled polyplexes and the 
proteins caveolin-1 and clathrin heavy chain.  PEI-Fol(1.1)/DNA colocalized primarily with 
caveolin-1 at 30 minutes post-transfection, suggesting that the complexes are predominantly 
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endocytosed via a caveolar process (Figure 3).  Correspondingly, PEI-Tf(25%)/DNA 
colocalized primarily with the clathrin heavy chain at 30 minutes post-transfection, suggesting 
that they enter cells via clathrin-mediated endocytosis.  Unmodified PEI/DNAcan be seen 
colocalized with both caveolin-1 and the clathrin heavy chain, indicating that these polyplexes 
likely enter cells through a nonspecific combination of both pathways. 
  
Uptake following selective endocytic inhibition with small molecule drugs 
Various drugs are capable of selectively inhibiting either clathrin- or caveolae-mediated 
endocytosis.  The drug chlorpromazine inhibits clathrin-mediated uptake by disassociating the 
clathrin-coated pits that form at ligand binding sites.30  Amantadine prevents clathrin-mediated 
uptake by blocking the budding of clathrin-coated vesicles into the cell.31  Caveolae are known to 
bud from microdomains on the cell surface that are rich in cholesterol.  The drug methyl-β-
cyclodextrin (mβCD) inhibits caveolar uptake by sequestering cholesterol on the cell surface.32  
Genistein, a tyrosine kinase inhibitor, blocks caveolar uptake by preventing the phosphorylation 
of caveolin, a scaffolding protein that is the main component of caveolae.33  Drug concentrations 
were chosen based on relevant literature and the ability of the drug to prevent the uptake of 150-
nm fluorescent polystyrene nanoparticles conjugated to either folate or transferrin (data not 
shown).  To test the effect of the inhibitor drugs on the uptake of folate- and transferrin-targeted 
PEI, polyplexes were labeled with the fluorescent DNA intercalator YOYO-1 and used to 
transfect cells that were subsequently subjected to flow cytometry (Figure 4a).  It is evident that 
uptake was not completely inhibited by any of the drugs at the concentrations tested.  However, 
the effects were more pronounced in certain targeted species than in others.  Uptake of folate-
targeted polyplexes was more substantially inhibited in the presence of genistein and mβCD than 
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chlorpromazine and amantadine as compared to PEI-Fol(1.1)/DNA uptake in the absence of 
drugs (p < 0.05).  Correspondingly, uptake of transferrin-targeted polyplexes was inhibited to a 
greater extent by chlorpromazine and amantadine than genistein and mβCD relative to PEI-
Tf(25%)/DNA uptake in the absence of drugs (p < 0.05).  Unmodified PEI/DNA uptake was 
reduced by both caveolae and clathrin inhibitors as compared to drug free conditions, indicating 
that it likely enters cells through a combination of both pathways (p < 0.05).  The non-specific 
effect of the drugs on the uptake of targeted complexes is likely a combination of their 
cytotoxicity (data not shown) as well as the potential for non-specific uptake of targeted 
complexes.  Nonetheless, the data suggest that the folate- and transferrin-targeted complexes are 
predominantly endocytosed by caveolae- and clathrin-mediated processes, respectively. 
 
Transfection following selective endocytic inhibition with small molecule drugs 
When unmodified as well as folate- and transferrin-targeted polyplexes were used to transfect 
HeLa cells in the presence of the same drugs tested above, inhibitors of caveolae-mediated 
endocytosis drastically reduced gene expression relative to drug-free conditions (p < 0.05) while 
inhibitors of clathrin-mediated endocytosis had no deleterious effects (Figure 4b).  Clathrin 
inhibition by chlorpromazine surprisingly increased the gene delivery efficiency of unmodified 
PEI/DNA by roughly two-fold and PEI-Tf(25%)/DNA by nearly three-fold relative to drug-free 
conditions (p < 0.05).  The observed increase in gene delivery efficiency with PEI-
Tf(25%)/DNA complexes suggests that efficient and successful gene delivery proceeds via a 
caveolae-mediated process in HeLa cells.  While chlorpromazine inhibits endocytosis by 
blocking the formation of clathrin-coated pits on the interior of the cell, it does not necessarily 
prevent the binding of targeted or non-targeted complexes to the cell membrane.  Thus, the 
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increase in transfection efficiency in the presence of chlorpromazine is likely due to increased 
uptake of polyplexes non-specifically bound to the cell membrane and internalized via caveolar 
or other uptake pathways.  The same rationale explains the transfection efficiency observed in 
cells treated with amantadine.  
 
Transfection following selective endocytic inhibition with siRNA 
To verify the transfection results obtained through drug-mediated inhibition of caveolar and 
clathrin-mediated endocytosis, transfections were performed in cells in which expression of 
caveolin-1 (CAV-1) or clathrin heavy chain (CLTC) was silenced by siRNA.  As a control, the 
transfection results were compared to HeLa cells treated with laminin (LAM) siRNA.  Gene 
silencing was performed using commercially available, pre-designed siRNA duplexes and 
confirmed by Western blot analysis of whole cell lysates (Figure 5a).  Laminin siRNA had no 
effect on caveolin-1 or clathrin heavy chain expression.  Confirming the results obtained through 
inhibition with small molecule drugs (Figure 4b), the down-regulation of caveolin-1 expression 
in HeLa cells decreased gene delivery by approximately 75% relative to laminin siRNA-treated 
cells irrespective of the presence of targeting ligands (p < 0.05, Figure 5b).  Down-regulation of 
clathrin heavy chain expression increased gene delivery approximately two-fold relative to 
laminin siRNA-treated cells irrespective of targeting (p < 0.05).  As described above, the 
increase is likely due to the internalization of non-specifically bound complexes by a caveolar 
pathway instead of a clathrin pathway. 
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Transfection in the presence of chloroquine and bafilomycin A1 
A major distinction between clathrin and caveolae-mediated endocytosis is trafficking to 
lysosomes.  Ligands entering the cell via the clathrin pathway are believed to ultimately enter 
lysosomes while ligands entering the cell via a caveolar pathway do not.  To investigate whether 
avoidance of lysosomes in the caveolar pathway is a component in successful gene delivery, 
transfections were performed in the presence of the lysosomotropic drug chloroquine.  When 
chloroquine is added to cells at 20 μM in the external medium, its intracellular concentration 
reaches 5 mM.34  The localized concentration within lysosomes is likely even higher.  Because of 
its aromatic ring structure, chloroquine is able to intercalate DNA, thereby causing a 
conformational change that is capable of inhibiting enzymatic DNA degradation.35,36  The 
addition of 5 mM chloroquine prevents total DNA digestion, as evidenced by the faint pGL3 
band seen in the corresponding lane (Figure 6a).  The degradation inhibition is more effective at 
higher chloroquine concentrations, resulting in brighter, more pronounced bands.   
 
Typically, chloroquine is used as an endosomal buffering agent with gene delivery vectors that 
lack the ability to buffer endosomes, such as polylysine.  Since PEI is an innate buffering agent, 
the effect of chloroquine in cells can be attributed to its ability to prevent lysosomal DNA 
degradation.  The addition of 20 µM chloroquine had only minimal effects on transgene 
expression in HeLa cells transfected with unmodified PEI/DNA and PEI-Fol(1.1)/DNA (Figure 
6b).  At least a portion of these polyplexes have entered via a caveolar pathway and thus 
presumably avoid lysosomes, thereby masking the potentially beneficial effects of chloroquine.  
However, for cells transfected with transferrin-targeted PEI, the addition of chloroquine yielded 
a two-fold increase in gene delivery relative to drug-free conditions (p < 0.05).  This suggests 
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that trafficking to lysosomes and plasmid degradation therein is a source of inefficiency for 
clathrin-targeted complexes.  Correspondingly, the data also suggest that avoidance of lysosomes 
by caveolae-targeted complexes is a contributing factor to their effective gene delivery.   
 
When treated simultaneously with chloroquine and bafilomycin A1, a V-type ATPase inhibitor 
that prevents the acidification of endosomes and thus the accumulation of chloroquine in 
lysosomes, chloroquine loses its advantageous effects on transferrin-targeted PEI relative to 
drug-free conditions (p < 0.05).  The noticeable decrease in transgene expression in cells treated 
with bafilomycin A1 relative to those transfected under drug-free conditions (p < 0.05) suggests 
that acidification—although not necessarily to the extent of reaching lysosomal pH—is a 
necessary component in PEI-mediated gene delivery regardless of uptake pathway.  The 
acidification may be necessary in a variety of cellular processes outside of the traditional 
endolysosomal pathway.  For example, bafilomycin A1 has been shown to affect several 
organelles, including parts of the Golgi complex, one of the target areas for caveolae-mediated 
uptake.37,38  Correspondingly, Mineo et al. have shown that caveolin-1 colocalizes with the V-
type ATPases affected by baflilomycin A1.38  Thus, the inhibitory effect of bafilomycin A1 may 
be due to its ability to prevent endosome acidification outside of the clathrin pathway, or 
bafilomycin A1 may interfere with the caveolar pathway in currently unknown ways. 
 
Polyplex pH measurement by ratiometric flow cytometry. 
To further explore the trafficking of polyplexes to lysosome-like pH environments, ratiometric 
flow cytometry was performed to measure the average pH surrounding targeted and untargeted 
gene delivery complexes.20  The fluorescence intensity of fluorescein decreases with pH over the 
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range of approximately pH 5 to 8.  By labeling targeted and untargeted PEI with both fluorescein 
and the pH-insensitive dye Alexa Fluor 633, the fluorescence intensity ratio of fluorescein to 
Alexa Fluor 633 (as measured by flow cytometry) can be used to measure the pH 
microenvironment of the respective complexes within cells at various times post-transfection 
(Figure 7).  All the tested complexes were exposed to mildly acidic environments during the first 
four hours post-transfection.  At that time, the average pH environment of PEI-Tf(25%)/DNA 
was lower than that surrounding untargeted PEI/DNA and PEI-Fol(1.1)/DNA complexes (p < 
0.05).  From four to eight hours, untargeted and transferrin-targeted polyplexes continued to be 
acidified while folate-targeted complexes remained at a near-constant, albeit acidic, pH.  
Presumably, this is because a large portion of the transferrin-targeted polyplexes and some of the 
untargeted polyplexes were within endosomes that were continually acidified by proton pumps in 
the endosomal membrane.  Meanwhile, the majority of folate-targeted polyplexes appeared to 
remain separate from the endolysosomal pathway, possibly within caveosomes that had fused 
with acidic early endosomes.  At eight hours post-transfection, PEI-Fol(1.1)/DNA resided in less 
acidic environments than unmodified PEI/DNA and PEI-Tf(25%)/DNA (p < 0.05).  As a 
consequence of entering cells primarily via the clathrin pathway, PEI-Tf(25%)/DNA was found 
at the lowest pH.  Untargeted PEI/DNA is believed to utilize both clathrin- and caveolar-
mediated uptake.  Thus, the combination of PEI/DNA within the higher pH caveolar pathway 
and the lower pH clathrin pathway results in a measured pH intermediate to the two extremes.  
By twelve hours post-transfection, untargeted and transferrin-targeted complexes reached near-
lysosomal conditions (pH 4.7) while the folate-targeted complexes did not (pH 5.1, p < 0.1).  
Only at twenty hours post-transfection did untargeted, transferrin- and folate-targeted complexes 
reach the same acidic pH.  The time at which DNA unpackages from its condensing agent is 
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unknown.  However, at twenty hours post-transfection it is likely that the complexes have 
dissociated with the free PEI being localized in lysosomes.   
 
Investigation of complex colocalization with EEA-1 and LAMP-1 
Ligands within the caveolar pathway are believed to either remain in caveosomes or fuse with 
early endosomes en route to their intracellular destination, while ligands within the clathrin 
pathway are trafficked from early endosomes to late endosomes and eventually lysosomes.  To 
investigate the effect of polyplex targeting on the intracellular pathway, fluorescently-labeled 
polyplexes were evaluated for colocalization with early endosome (EEA-1) and lysosome 
(LAMP-1) markers at ten hours post-transfection (Figure 8).  Unmodified PEI/DNA appear to 
be found equally within early endosomes and lysosomes at ten hours post-transfection.  However, 
a greater portion of folate-targeted complexes appear to be within early endosomes than 
lysosomes.  Correspondingly, transferrin-targeted complexes appear to associate more with 
lysosomes than early endosomes.  The colocalization data support the pH tracking data of Figure 
7, which suggests that untargeted and transferrin-targeted complexes have entered lysosomal-like 
conditions (pH 4.8) at ten hours post-transfection while folate-targeted complexes are primarily 
still in early and late endosomes (pH 5.3). 
 
DISCUSSION 
 
Practical gene delivery vectors will likely utilize some form of cell-specific targeting.  Because 
of this, it is important that studies of the intracellular behavior of gene delivery vectors include 
the effects of cell targeting and associated endocytic trafficking.  Recent work has highlighted 
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the importance of caveolar uptake and processing over the clathrin pathway in successful gene 
delivery in multiple cell types.27,39,40 To this end, the work presented here addresses the 
differences in processing of PEI gene delivery complexes targeted to clathrin and caveolar 
pathways using transferrin and folate, respectively.   
 
The ability of caveolae inhibitor drugs (Figure 4b) and siRNA-mediated caveolin-1 down-
regulation (Figure 5b) to dramatically reduce gene expression in HeLa cells irrespective of 
vector targeting suggests that caveolar processing is the efficient means of PEI-containing 
polyplex trafficking in HeLa cells.  If both pathways were equally capable of successful gene 
delivery, transgene expression mediated by transferrin-targeted complexes would be expected to 
decrease as a result of clathrin inhibition yet be unaffected by caveolar inhibition.  Since caveolar 
inhibition alone has a negative effect on transgene expression, the results presented here indicate 
that caveolar, not clathrin, processing yields successful gene delivery.  This is not wholly 
surprising as certain viruses, such as SV40, are known to infect cells through a caveolar pathway.  
To understand the deficiencies in the clathrin pathway—and thus the important intracellular steps 
in successful gene delivery—it is useful to compare the differences in cellular processing of 
ligands within the two pathways.  With regard to polyplex gene delivery, the most important 
difference between the two routes is trafficking to lysosomes.  Thus, it seems likely that a portion 
of the efficiency of complexes internalized via the caveolar pathway is avoidance of lysosomes 
and degradation therein. 
 
At elevated concentrations chloroquine is able to prevent the enzymatic degradation of plasmid 
DNA by affecting a conformational change in DNA that is believed to prohibit the binding of 
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DNAse.  As a lysosomotropic agent, chloroquine accumulates preferentially in lysosomes.  Thus, 
its ability to inhibit DNAse digestion is limited to DNA that has entered lysosomes.  In the 
context of the work presented here, chloroquine improved the gene delivery efficiency of only 
transferrin-targeted polyplexes (Figure 6b).  This suggests that lysosomal trafficking is an 
important barrier for complexes entering the cell through the clathrin pathway.  The beneficial 
effects of chloroquine on PEI-Tf(25%)/DNA transfection could be elminated by preventing 
chloroquine accumulation in lysosomes through the use of bafilomycin A1.  However, 
bafilomycin A1 alone reduced the gene delivery efficiency of not only transferrin-targeted 
polyplexes, but also unmodified and folate-targeted polyplexes.  This reduction in efficiency has 
been interpreted to suggest that endosome acidification is an essential step in successful gene 
delivery.41  However, Mineo et al. have shown that caveolin-1 colocalizes with the same V-type 
ATPases inhibited by bafilomycin A1.38  Thus, the reduction in gene delivery by bafilomycin A1 
may be due to effects outside of its ability to prevent endosome acidification during clathrin-
mediated uptake—bafilomycin might also interfere with the caveolar pathway. 
 
Measurement of the pH environment of PEI-based gene delivery complexes suggests that all 
three types of polyplexes, regardless of caveolar- or clathrin-mediated internalization, are 
exposed to the acidic environments of early endosomes during the first four hours post-
transfection.  Based on the significant decrease in transgene expression in the presence of 
bafilomycin A1 (Figure 6b), this acidification appears to be an essential step in efficient gene 
delivery.  Evidence suggests that some caveolar vesicles fuse with early endosomes for sorting 
during their movement through the cell.14,42  The acidic conditions surrounding folate-targeted 
complexes (Figure 7) support the fusion hypothesis.  After four hours post-transfection, the 
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differences between folate-targeted, transferrin-targeted and untargeted polyplexes became 
evident.  From four to eight hours, folate-targeted complexes remained at near constant pH (pH 
5.5) while transferrin-targeted and untargeted complexes continued to be acidified.  Early 
endosomes typically exhibit a pH of 6.0.  Keeping in mind that the ratiometric assay employed 
measures the average pH of all polyplexes within the cells, it is likely that some complexes 
reside within environments at a higher or lower pH than recorded.  Thus, it is conceivable that 
during four to eight hours post-transfection a portion of the folate-targeted complexes could be 
found sequestered in early endosomes while others had moved into more acidic environments.  
With their lower and steadily decreasing pH from four to eight hours, it appears that the 
transferrin-targeted and untargeted complexes were localized in late endosomes en route to 
lysosomes.  Localization of untargeted PEI/DNA in higher pH environments than transferrin-
targeted polyplexes suggests that a smaller fraction of the untargeted complexes were present in 
the pathway from the endosomes to lysosomes.  This supports the previous data suggesting that 
untargeted complexes enter through a non-specific combination of both caveolar and clathrin 
pathways.  At twelve hours post-transfection, the pH 4.7 environment surrounding transferrin-
targeted and untargeted complexes suggests that they had entered lysosomes.  At the same time, 
the bulk of folate-targeted complexes appeared to be entering the late endosome at pH 5.0.  At 
twenty hours post-transfection, the folate-targeted complexes joined the transferrin-targeted and 
untargeted complexes in lysosomes.  Thus, while folate-targeted complexes did not completely 
bypass acidic environments, they appeared to spend a greater amount of time in early endosomes 
and were ultimately trafficked to lysosomes at a slower rate than either transferrin-targeted or 
untargeted complexes.   
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In summary, cell targeting can influence the intracellular processing of PEI-containing gene 
delivery vehicles.  The results presented here suggest that complexes targeted to the caveolar 
pathway result in efficient gene delivery in HeLa cells while those targeted to the clathrin 
pathway do not.  While both endocytic routes involve acidification in the early endosomes, the 
caveolar pathway avoids rapid and direct trafficking to the more acidic late endosomes and 
lysosomes, suggesting that this lysosomal trafficking is a source of inefficiency with the clathrin 
pathway. 
 
MATERIALS AND METHODS 
 
Materials 
Folic acid, human apo-transferrin, N-hydroxysuccinimide, N,N’-dicyclohexylcarbodiimide, 25-
kDa branched polyethylenimine, genistein, chlorpromazine, amantadine and the ProteoQuest 
colorimetric Western blotting kit were obtained from Sigma-Aldrich (St. Louis, MO).  Traut’s 
reagent (2-iminothiolane), ninhydrin, Ellman’s reagent, sulfo-KMUS and BCA protein assay kits 
were purchased from Pierce Chemical Company (Rockford, IL).  Methyl-β-cyclodextrin was 
obtained from Roquette America, Inc. (Keokuk, IA).  Lipofectamine 2000, the fluorescent dyes 
fluorescein isothiocyanate (FITC), YOYO-1, Alexa Fluor 488, Alexa Fluor 633, and the 
antibody labeling kits Zenon Alexa Fluor 546 Mouse IgG1 and Zenon Alexa Fluor 647 Mouse 
IgG1 were obtained from Invitrogen (Carlsbad, CA).  Mouse anti-clathrin heavy chain IgG1 and 
mouse anti-early endosome IgG1 were obtained from Santa Cruz Biotechnology (Santa Cruz, 
CA).  Mouse anti-caveolin-1 IgG1 and mouse anti-lysosomal associated membrane protein-1 
IgG1 were obtained from BD Biosciences (Franklin Lakes, NJ).  Pre-designed short interfering 
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RNA (siRNA) targeted towards the clathrin heavy chain was obtained from Qiagen (Valencia, 
CA).  Pre-designed siRNAs targeted towards laminin and caveolin-1 were obtained from 
Dharmacon (Lafayette, CO). 
  
Cells and plasmids 
The HeLa human cervical carcinoma cell line used in this study was a gift from Dr. Sandra 
McMasters (University of Illinois, Urbana, IL).  The cells were cultured according to their 
ATCC protocols at 37 °C and 5% CO2 in Dulbecco’s modified Eagle’s medium.  The growth 
medium was supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.  The 
5.3-kilobase expression vector pGL3 (Promega, Madison, WI) coding for the luciferase gene 
driven by the SV40 promoter and enhancer, was grown in DH5α E. coli (Gibco BRL, Rockville, 
MD) and purified with a commercial plasmid purification kit (Bio-Rad, Hercules, CA). 
 
Generation of folate-targeted PEI 
Folic acid was conjugated to PEI according to the procedure of Guo et al.43  Briefly, folic acid 
was dissolved in dimethylsulfoxide with a 1.1 molar excess of both N-hydroxysuccinimide 
(NHS) and N,N'-Dicyclohexylcarbodiimide (DCC).  The reaction was allowed to stir overnight 
at room temperature.  The following day, the insoluble dicyclohexylurea byproduct was removed 
by filtration.  The NHS-folate product was collected, quantified by ultraviolet absorption at 363 
nm and stored at 4 °C until needed.  NHS-activated folate was conjugated to the primary amines 
of 25-kDa branched PEI by dissolving both in 0.1 M sodium bicarbonate buffer (pH 8.3) at the 
desired labeling ratio and stirring overnight at room temperature.  The PEI-folate product was 
purified from reactants by gel filtration chromatography (PD-10, GE Healthcare, Uppsala, 
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Sweden) and characterized using a ninhydrin assay (PEI quantification) and ultraviolet 
absorption at 363 nm (folate quantification). 
 
Generation of transferrin-targeted PEI 
Human apo-transferrin was conjugated to PEI using the heterobifunctional crosslinker sulfo-
KMUS.  Briefly, 25-kDa branched PEI was first thiolated with 2-iminothiolane in PBS 
containing 5 mM EDTA and purified by gel filtration chromatography (PD-10, GE Healthcare, 
Uppsala, Sweden).  The presence of thiol groups was quantified with Ellman’s reagent.  Sulfo-
KMUS was reacted separately with the primary amines of human apo-transferrin and purified by 
gel filtration chromatography (PD-10, GE Healthcare, Uppsala, Sweden) to generate a thiol-
reactive form of the protein.  The thiol-reactive transferrin and thiolated PEI were then combined 
at a 1:1 molar ratio in PBS containing 5 mM EDTA and allowed to react overnight at 4 °C.  The 
resulting PEI-transferrin conjugate was purified from reactants using a 100,000 MWCO 
centrifugal filter (Millipore, Temecula, CA).  The concentration of PEI in the retentate was 
quantified using a ninhydrin assay.  Transferrin covalently linked to PEI was quantified using a 
BCA protein assay.  Prior to transfection, the apo-transferrin was loaded with iron by adding two 
molar equivalents of ferric citrate to the PEI-transferrin conjugate and used without further 
purification. 
 
Polyplex preparation and transfection 
Cells were plated in 24-well tissue culture plates at 5 × 104 cells/well 24 h prior to transfection.  
DNA/polymer complexes were prepared at room temperature by dissolving 4 µg of DNA in 
approximately 100 μl of Mili-Q water and adding an equal volume of polymer solution to 
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achieve the desired polymer:DNA weight ratio.  Complexes were then incubated at room 
temperature for 20 min.  For transfections performed in the presence of caveolae inhibitors (50 
μg/ml  genistein, 10 mg/ml methyl-β-cyclodextrin) or clathrin inhibitors (5 μg/ml 
chlorpromazine, 1 mM amantadine), the growth medium was replaced with folate-free, serum-
free medium containing the desired drug one hour prior to transfection.  For transfections in the 
presence of 20 μM chloroquine, 10 nM bafilomycin A1 or both, the growth medium was 
replaced with folate-free, serum-free medium containing the desired drug immediately prior to 
transfection.  If no drugs were present, the medium was also replaced with folate-free, serum-
free medium immediately prior to transfection.  At the time of transfection, 50 µl of polyplex 
solution was added to each well (1 µg plasmid/well).  The transfection medium was replaced 
with serum-supplemented growth medium 2 h post-transfection.  Luciferase expression was 
quantified 24 h post-transfection using the Promega luciferase assay system (Promega, Madison, 
WI).  Luciferase activity was measured in relative light units (RLU) using a Lumat LB 9507 
luminometer (Berthold, GmbH, Germany) and normalized to total cell protein using a BCA 
protein assay kit. 
 
Down-regulation of caveolin-1 and clathrin heavy chain expression 
Cells were plated in 6-well tissue culture plates at 1 × 105 cells/well 24 h prior to treatment.  
Twenty minutes prior to transfection, siRNA was complexed with Lipofectamine 2000 in Opti-
MEM (Gibco, Rockville, MD) according to the manufacturer’s protocol.  Complexes were then 
added to cells in serum-supplemented media at a final concentration of 33 nM siRNA.  The cells 
were washed, trypsinized and replated in 60-mm dishes 24 h post-transfection.  After another 48 
h, the cells were plated in 24-well tissue culture plates at 5 × 104 cells/well and allowed to grow 
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for 24 h before transfection and analysis as described above.  Western blots of whole cell lysates 
were performed to verify the siRNA-mediated silencing of clathrin heavy chain (CLTC) and 
caveolin-1 (CAV-1) using the ProteoQuest colorimetric Western blotting kit.  Caveolin-1 and 
clathrin heavy chain primary antibodies were used at a 1:500 dilution. 
 
Flow cytometry 
To prepare flow cytometry samples, DNA complexes were formed with either targeted or 
untargeted polymers as described above, save for the addition of YOYO-1 at the ratio 30 nl 
YOYO-1 per 1 µg of DNA (one YOYO-1 molecule per 50 DNA base pairs).  Transfection was 
carried out as described previously.  Two hours post-transfection, the cells were rinsed twice 
with 0.001% SDS in PBS and then PBS to remove surface-bound complexes.  Next, 100 µl of 
0.25% trypsin in PBS was added to each well.  The cells and trypsin were allowed to incubate for 
five to ten minutes before 400 µl of 3.7% formaldehyde was added to each well.  The cells were 
then collected and stored on ice.  FACS analyses were performed on a BD Biosciences LSR II 
flow cytometer (Franklin Lakes, NJ).  Data were analyzed using the FCS Express software 
package (De Novo Software, Los Angeles, CA). 
 
Competitive inhibition of uptake and transfection 
Unlabeled and YOYO-1 labeled DNA/polymer complexes were prepared as described 
previously.  Thirty minutes prior to transfection, the growth medium on the HeLa cells was 
replaced with folate-free, serum-free medium containing the desired concentrations of either free 
folic acid or iron-loaded transferrin and incubated at 4 °C.  At the time of transfection, 50 μl of 
the polyplex solution was added to each well and the cells were moved to 37 °C.  The 
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transfection medium was replaced with serum-supplemented growth medium 30 minutes post-
transfection.  The cells were then subjected to either flow cytometry or allowed to grow for 24 h 
prior to lysis and reporter gene measurement. 
 
Investigation of colocalization 
The primary amines of unmodified or targeted PEI samples were reacted with NHS-ester 
functionalized Alexa Fluor 488 in 0.1 M sodium bicarbonate buffer (pH 8.3) for 1 h.  Labeled 
PEI was purified from unreacted dye by gel filtration chromatography (PD-10, GE Healthcare, 
Uppsala, Sweden).  Polyplexes were formed as described above using a combination of both 
Alexa Fluor 488-labeled and unlabeled polymers.  HeLa cells, seeded at 2 × 105 cells/well and 
grown overnight in 6-well plates containing a coverslip in each well, were incubated at 4 °C with 
folate-free, serum-free medium containing fluorescent polyplexes for 30 minutes before moving 
the plates to 37 °C.  To investigate polyplex colocalization with clathrin heavy chain (CLTC) or 
caveolin-1 (CAV-1), 30 min post-transfection the cells were washed with PBS, permeabilized 
with 0.1% Triton X-100 in PBS, stained with either mouse anti-caveolin-1 IgG1 antibody or 
mouse anti-clathrin heavy chain IgG1 antibody and fixed with 3.7% formaldehyde in PBS.  The 
clathrin heavy chain and caveolin-1 antibodies were fluorescently labeled after addition using the 
Zenon Alexa Fluor 546 mouse IgG1 labeling kit as per the manufacturer’s instructions.  To 
investigate early endosome antigen (EEA-1) and lysosomal associated membrane protein-1 
(LAMP-1) colocalization, the cells were washed with PBS, permeabilized with 0.1% Triton X-
100 in PBS, stained with either mouse anti-LAMP-1 IgG1 or mouse anti-EEA-1 IgG1 and fixed 
with 3.7% formaldehyde in PBS at 10 h post-transfection.  The LAMP-1 and EEA-1 antibodies 
were fluorescently labeled after addition using the Zenon Alexa Fluor 647 mouse IgG1 labeling 
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kit as per the manufacturer’s instructions.  Mounted cells were visualized with an Olympus 
Model BX60 confocal microscope equipped with a 100x oil immersion lens as well as Argon, 
Krypton and HeNe lasers for visualizing the Alexa Fluor 488 (λex = 488 nm), Alexa Fluor 546 
(λex = 568 nm) and Alexa Fluor 647 (λex = 633 nm) signals, respectively.  Separate, 
representative images of each dye were captured and overlaid with Image J software (NIH).  
 
DNAse/chloroquine gel electrophoresis 
Plasmid DNA (pGL3) and DNAse I (Promega, Madison, WI) were mixed with various 
chloroquine concentrations in DNAse reaction buffer and immediately incubated at 37 °C for 10 
minutes prior to DNAse deactivation.  Deactivation was achieved by adding DNAse stop 
solution and heating at 65 °C for 10 minutes.  The mixture was then subjected to agarose gel 
electrophoresis, stained with ethidium bromide and visualized using a Gel Doc 2000 gel 
documentation system (Bio-Rad, Hercules, Ca). 
 
Ratiometric flow cytometry 
Unmodified or targeted PEI samples were reacted with fluorescein isothiocyanate (FITC) and 
NHS-ester functionalized Alexa Fluor 633 in 0.1 M sodium bicarbonate buffer (pH 9.6) for 1 h 
to generate dual-labeled polymer.  Labeled PEI was purified from unreacted dye by gel filtration 
chromatography (PD-10, GE Healthcare, Uppsala, Sweden).  Targeted and untargeted complexes 
were formed with labeled and unlabeled polymers as described previously.  HeLa cells, seeded in 
24-well plates at 5 × 104 cells/well and grown overnight, were transfected with fluorescent 
complexes for one hour in folate-free, serum-free media before the cells were washed with 
0.001% SDS in PBS and PBS and the serum-supplemented growth medium was replaced.  
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Transfections were staggered from 2 to 20 hours before FACS analysis to allow the cells to be 
harvested and analyzed simultaneously.  pH standards were created in parallel with the samples 
by incubating cells transfected with the fluorescent polyplexes in a buffer consisting of 150 mM 
NaCl and either 50 mM sodium phosphate (adjusted to pH 7.6, pH 7.0 or pH 6.5), 50 mM MES 
(adjusted to pH 6.0 or pH 5.5) or 50 mM sodium acetate (adjusted to pH 5.0 or pH 4.5).  The 
sodium ionophore monensin was added to the standard cells at a final concentration of 10 μM 
prior to analysis to equilibrate the intra- and extracellular pH. 
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TITLES AND LEGENDS TO FIGURES 
 
Figure 1.  (a) In vitro transfection of HeLa cells with PEI or PEI-Fol at indicated polymer:DNA 
weight ratios.  Luciferase activity in the cell lysates is reported as relative light units (RLU) 
normalized by the mass of total protein in the lysate.  (b) Uptake of YOYO-1 labeled pGL3 and 
PEI or PEI-Fol(1.1) polyplexes (polymer:DNA weight ratio of 0.5:1) in HeLa cells.  (c)  In vitro 
transfection of HeLa cells with PEI or PEI-Fol(1.1) polyplexes (polymer:DNA weight ratio of 
0.5:1) in the presence of free folic acid.  Luciferase activity in the cell lysates is reported as 
relative light units (RLU) normalized by the mass of total protein in the lysate.  (d)  Uptake of 
YOYO-1 labeled pGL3 and PEI or PEI-Fol(1.1) polyplexes (polymer:DNA weight ratio of 0.5:1) 
in the presence of free folic acid.  Fluorescence values were normalized to the median 
fluorescence of cells grown in the absence of free folate.  (N = 3; error bars represent standard 
deviation; ∗, †, ‡ = p < 0.05, ∗∗ = p < 0.1). 
 
Figure 2.  (a)  In vitro transfection of HeLa cells with PEI or PEI-Tf at a total polymer:DNA 
weight ratio of 0.5:1.  The percent composition of PEI-Tf in the polyplexes was varied between 
10% and 100%.  Luciferase activity in the cell lysates is reported as relative light units (RLU) 
normalized by the mass of total protein in the lysate.  (b)  Uptake of YOYO-1 labeled pGL3 and 
PEI or PEI-Tf(25%) polyplexes (polymer:DNA weight ratio of 0.5:1) in HeLa cells. (c)  In vitro 
transfection of HeLa cells with PEI or PEI-Tf(25%) polyplexes (polymer:DNA weight ratio of 
0.5:1) in the presence of free transferrin.  Luciferase activity in the cell lysates is reported as 
relative light units (RLU) normalized by the mass of total protein in the lysate.  (d)  Uptake of 
YOYO-1 labeled pGL3 and PEI or PEI-Tf(25%) polyplexes (polymer:DNA weight ratio of 
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0.5:1) in the presence of free transferrin.  Fluorescence values were normalized to the median 
fluorescence of cells grown in the absence of free transferrin.   (N = 3; error bars represent 
standard deviation; ∗, †, ‡ = p < 0.05, ∗∗ = p < 0.1, ∗∗∗ = p < 0.15). 
 
Figure 3.  Confocal fluorescence micrographs of HeLa cells transfected with PEI, PEI-Fol(1.1) 
or PEI-Tf(25%) polyplexes (green) and immunostained for caveolin-1 or clathrin heavy chain 
(red) at 30 min post-transfection.  Complexes were formed at a total polymer:DNA ratio of 0.5:1. 
 
Figure 4.  (a) Normalized median fluorescence of HeLa cells transfected with YOYO-1 labeled 
pGL3 and PEI, PEI-Fol(1.1), or PEI-Tf(25%) polyplexes (polymer:DNA weight ratio of 0.5:1) in 
the presence of caveolae (genistein, 50 μg/ml; methyl-β-cyclodextrin, 10 mg/ml) and clathrin 
(chlorpromazine, 5 μg/ml; amantadine-1 mM) inhibitors.  Fluorescence values were normalized 
to the median fluorescence of cells grown in the absence of drugs.  (b)  Normalized in vitro 
transfection efficiency of PEI, PEI-Fol(1.1) or PEI-Tf(25%) polyplexes (polymer:DNA weight 
ratio of 0.5:1) in HeLa cells in the presence of caveolae (genistein, 50 μg/ml; methyl-β-
cyclodextrin, 10 mg/ml) and clathrin (chlorpromazine, 5 μg/ml; amantadine, 1 mM) inhibitors.  
Luciferase activity in the cell lysates is reported as relative light units (RLU) normalized by the 
mass of total protein in the lysate.  Luciferase activity of drug-treated cells was normalized to 
cells grown in the absence of any drugs.  (N = 3; error bars represent standard deviation; ∗, †, ‡ 
= p < 0.05 compared to the same polyplexes in the absence of drug). 
 
Figure 5.  (a)  Western blot of caveolin-1 and clathrin heavy chain expression in whole HeLa 
cell lysates following transfection with siLAM, siCAV-1, or siCLTC.  (b)  Normalized in vitro 
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transfection efficiency of PEI, PEI-Fol(1.1) or PEI-Tf(25%) polyplexes (polymer:DNA weight 
ratio of 0.5:1) in HeLa cells treated with siRNAs.  Luciferase activity in the cell lysates is 
reported as relative light units (RLU) normalized by the mass of total protein in the lysate.  
Luciferase activity of siRNA-treated cells was normalized to cells treated with siLAM.  (N = 6; 
error bars represent standard deviation; ∗, †, ‡ = p < 0.05). 
 
Figure 6.  (a) Gel electrophoresis of pGL3 incubated with DNAse I in the presence of various 
chloroquine concentrations at 37 °C for 10 min.  (b)  Normalized in vitro transfection efficiency 
of HeLa cells with PEI, PEI-Fol(1.1) or PEI-Tf(25%) polyplexes (polymer:DNA weight ratio of 
0.5:1) in the absence and presence of 20 μM chloroquine, 10 nM bafilomycin A1 or both.  
Luciferase activity in the cell lysates is reported as relative light units (RLU) normalized by the 
mass of total protein in the lysate.  Luciferase activity of drug-treated cells was normalized to 
cells grown in the absence of any drug.  (N = 3; error bars represent standard deviation; ∗, ∗∗, †, 
‡ = p < 0.05, ††, ‡‡ = p < 0.1 compared to the same polyplexes in the absence of drug). 
 
Figure 7.  Local pH measurement of HeLa cells transfected with PEI, PEI-Fol(1.1) or PEI-
Tf(25%) polyplexes (polymer:DNA weight ratio of 0.5:1) at 2, 4, 8, 12 and 24 h post-
transfection.  (N = 3; error bars represent standard deviation; ∗, † = p < 0.05, ‡‡ = p < 0.1 
compared to the other polyplexes at the same time). 
 
Figure 8.  Confocal fluorescence micrographs of HeLa cells transfected with PEI, PEI-Fol(1.1) 
or PEI-Tf(25%) polyplexes (green) and immunostained for early endosome marker EEA-1 or 
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lysosome marker LAMP-1 (red) at 10 h post-transfection.  Complexes were formed at a total 
polymer:DNA ratio of 0.5:1. 








